Metabolon at ARVO 2025 Annual Meeting
Dates: May 4–8, 2025
Location: Salt Lake City, Utah
Visit the Official Event Website
Join Metabolon at ARVO 2025
Metabolon is attending the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), the premier global event dedicated to vision and ophthalmology research. This meeting brings together leading scientists, clinicians, and industry professionals to discuss the latest advancements in eye health, disease mechanisms, and therapeutic developments.
About ARVO 2025
The ARVO Annual Meeting is the largest and most influential conference in vision research, attracting experts from academia, industry, and clinical practice. The event provides a platform for cutting-edge scientific presentations, interactive discussions, and collaborations aimed at advancing treatments for retinal diseases, glaucoma, ocular oncology, corneal disorders, and more.
With a diverse program covering fundamental research to clinical applications, ARVO fosters the exchange of knowledge that accelerates innovation in vision science.
Scientific Themes and Program Highlights
ARVO 2025 will feature high-impact research, technological advancements, and emerging therapies in vision and ophthalmology, with key themes including:
- Retinal Disease and Therapeutics – Advances in age-related macular degeneration (AMD), diabetic retinopathy, and gene therapy.
- Corneal and Ocular Surface Disorders – Innovations in transplantation, tissue engineering, and wound healing.
- Glaucoma and Optic Neuropathy – New insights into pathophysiology, biomarkers, and neuroprotection strategies.
- Ocular Oncology and Genetics – Precision medicine approaches and genetic underpinnings of eye diseases.
- Metabolomics in Ophthalmology – The role of metabolism and biomarkers in eye health and disease.
Why Metabolon is Attending ARVO 2025
Metabolomics is playing a critical role in vision science by uncovering metabolic pathways linked to ocular diseases, therapeutic responses, and biomarker discovery. As a global leader in metabolomics, Metabolon provides comprehensive solutions to support multiomics research into genetic, environmental, and lifestyle factors effecting ophthalmology.
At ARVO 2025, Metabolon will highlight how our metabolomics and bioinformatics capabilities are advancing ophthalmology research by:
- Revealing metabolic signatures of eye diseases, helping identify novel biomarkers for early diagnosis and treatment monitoring.
- Enhancing drug development workflows for retinal and corneal disorders, providing metabolic insights that improve therapeutic efficacy and precision medicine approaches.
- Supporting ophthalmic disease research by integrating metabolomics with genomics and proteomics to deliver a holistic understanding of disease mechanisms.
- Advancing neuro-ophthalmology studies by characterizing metabolic changes in glaucoma, optic neuropathy, and neurodegenerative eye diseases.
- Contributing to population health studies by examining the metabolic impact of diet, environmental factors, and systemic diseases on eye health.
Metabolon is committed to transforming ophthalmic research by delivering data-driven insights that enhance precision medicine, disease prevention, and therapeutic innovation.
Keynote Speakers and Featured Sessions
ARVO 2025 will feature top vision science researchers presenting the latest discoveries in ophthalmology and vision research. Stay tuned for the official speaker lineup and session details.
View All Speakers and Sessions
Where to Find Metabolon at ARVO 2025
We will provide details on our booth location and exhibition activities as the event approaches. To schedule a meeting with our metabolomics and bioinformatics specialists, please use the contact form on this page.
